BSG and hepatocellular carcinoma: Optimal cutoff point of serum CD147 was 3.3 ng/ml, which provided a sensitivity of 83.9% (52 of 62 HCC patients correctly classified) and a specificity of 76.0% (19 of 25 controls correctly classified).